Tag: Jennifer Doudna

October 5, 2017

4 Gene Therapy Stocks to Watch in 2017

At the halfway mark of 2017, here's a look at how these four gene therapy companies are performing so far...
February 21, 2017

Thom Calandra: Investing in Gene-editing Stocks

Thom Calandra is known to investors in the resource space. Recently, he wrote about biotechnology and started his own index...
February 15, 2017

The CRISPR-Cas9 Patent Dispute

The US Patent Office has ruled “no interference in fact” on CRISPR-Cas9 Patent dispute.
November 3, 2016

Best Regions for Genetics Research

The US, China and the UK are the top regions for genetics research.
March 10, 2016

After Hot IPO Editas Medicine Bogged Down by CRISPR/Cas9 Legal Issues

Editas Medicine's share price went on a tear following its IPO in February. In the last two days, however, it's...